Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response
Clinical trial NCT04577482 · COMPLETED
Trial details
- NCT number
- NCT04577482
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-07
- Primary completion
- 2022-09-03
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.